CO-FINANCED PROJECTS
Project name | CInTech: Polo Tecnológico de Inovação, Translação e Industrialização de Medicamentos Injetáveis Complexos
Project code | C644865576-00000005
Component | Investment and innovation
Investment | Mobilizing Agendas/Alliances for Reindustrialization
Start date | 01-01-2023
Completion date | 31-12-2025
Total project value | EUR 29,47 million
The CInTech aims at creating and empowering the 1st Technological Hub for Innovation, Translation, and Industrialization dedicated to complex injectable medications: innovative technological platforms capable of incorporating different therapeutic agents for oncology (small molecules, peptides, nucleic acids). It will be a unique Hub comprising 3 Centers: an I&I laboratory for knowledge and technology translation; development, process engineering, and scale-up aiming at analytical development and prototyping; GMP manufacturing, capable of responding to the production of injectables, developed by the consortium or by third parties. It will be a structuring and mobilizing project, with a high impact on the economy and scientific innovation in Portugal, promoting synergistic cooperation between SMEs, non-SMEs, and R&D institutions, and the creation of a highly differentiated portfolio that, in addition to the benefits for the patient, constitutes a contribution to the exportation of high-technology goods and services.
Main objectives:
The CInTech Consortium is a strategic and synergistic alliance that brings together Portuguese industries in pharmaceuticals (Bluepharma - Pharmaceutical Industry, S.A.), intralogistics (JPM - Automation and Industrial Equipment, S.A.), engineering (JointSteel - Process Technologies, S.A.), and biotechnology (Biotrend - Innovation and Biotechnology Engineering, S.A.), along with some of the most dynamic and innovative centers (University of Coimbra and International Iberian Nanotechnology Laboratory) aiming to deliver a total of seven products, processes, and/or services (PPS):
• PPS1 (product) - New polymeric excipient with potential for use in complex injectable formulations with a patent application submitted;
• PPS2 (process, service) - Unit for granting, production, and analytical control of nucleic acids;
• PPS3 (product) - New lipid-based technological platform for therapeutic agent delivery;
• PPS4 (product) - New polymer-based technological platform for therapeutic agent delivery;
• PPS5 (product) - New set of customized process equipment for the pharmaceutical industry;
• PPS6 (product) - New digital platform for management and monitoring of process equipment;
• PPS7 (process, service) - Construction and empowerment of Centers dedicated to the development and GMP manufacturing of complex injectables.
Our vision is to be a leading company in the manufacturing and supply of process solutions, meeting and exceeding the needs of our customers, based on the combination of our strengths and experience in the markets we operate in.
SOCIAL
CONTACTS
Portugal:
José Bastos
M. +351 968 274 830
E. jose.bastos@jointsteel.com
Headquarters and Industrial Unit
Zona Industrial da Farrapa
4540-267 Chave - Arouca
M. +351 256 026 710
E. info@jointsteel.com
GPS Coordinates:
Latitude: 40º53'59.29"N
Longitude: 8º21'37.07"W
BeNeLux:
© COPYRIGHT 2024, JOINTSTEEL PROCESS TECHNOLOGIES